BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...Active Motif Inc. Lysine-specific demethylases Cancer Preclinical $15.0 Alexandria Venture Investments; Evotec AG (Xetra:EVT) ; Magna Group...
Items per page:
1 - 1 of 1
BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...Active Motif Inc. Lysine-specific demethylases Cancer Preclinical $15.0 Alexandria Venture Investments; Evotec AG (Xetra:EVT) ; Magna Group...
Items per page:
1 - 1 of 1